PulseAugur
EN
LIVE 16:23:27
中文(ZH) 江西生物:拟全球发售3623.45万股H股,发售价不超13.06港元

Jiangxi Bio plans H-share offering; Lithium futures open to overseas traders

Jiangxi Bio is planning a global offering of 36.23 million H shares, with the offering price not exceeding HK$13.06 per share. The company expects its shares to begin trading on the Hong Kong Stock Exchange on June 30, 2026. In related news, the Guangzhou Futures Exchange will allow overseas traders to participate in lithium carbonate futures and options trading starting July 3rd, aiming to enhance China's pricing influence in the global new energy materials sector. AI

IMPACT This news has minimal direct impact on AI operators, focusing instead on financial markets and corporate offerings.

RANK_REASON The cluster contains a planned IPO and a significant development in the internationalization of a key commodity futures market. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Jiangxi Bio plans H-share offering; Lithium futures open to overseas traders

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Jiangxi Biology: Plans to globally offer 36.2345 million H shares, with an offering price not exceeding HK$13.06

    36氪获悉,江西生物在港交所公告,公司拟全球发售36,234,500股H股,香港发售股份3,623,500股H股,国际发售股份32,611,000股H股,另有15%的超额配股权;发售价不超每股13.06港元;预期股份将于2026年6月30日开始在香港联交所买卖。